Peter Maccallum Cancer Centre, Australia
Clinical trials sponsored by Peter Maccallum Cancer Centre, Australia, explained in plain language.
-
Zapping resistant tumors: could radiation extend the life of current breast cancer therapy?
Disease control Not yet recruitingThis trial is for people with ER-positive, HER2-negative advanced breast cancer whose disease has started to grow in a few spots while on hormone therapy and a CDK4/6 inhibitor. It tests whether adding targeted radiation (SABR) to those spots allows patients to stay on their curr…
Phase: NA • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New radioactive therapy targets mysterious cancers
Disease control Not yet recruitingThis phase 2 trial tests a new radioactive drug, Lu-177 FAP-2286, in 20 patients with cancer of unknown primary (CUP). The drug targets a protein found on cells near tumors, delivering radiation directly to the cancer. The main goal is to see if the treatment can shrink tumors or…
Phase: PHASE2 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New study to reveal hidden toll of breast cancer drugs on fertility
Knowledge-focused Not yet recruitingThis study will follow 75 women aged 18-42 with early-stage triple-negative breast cancer who are receiving chemotherapy plus immunotherapy before surgery. Researchers will measure hormone levels, track menstrual patterns, and use questionnaires to see how treatment affects ovari…
Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC